Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsPeripheral Blood Stem Cell TransplantationMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningCombined Modality TherapyTreatment OutcomeRemission InductionSalvage TherapyEtoposideStem CellsCyclophosphamideDisease-Free SurvivalHodgkin DiseaseLymphoma, Non-HodgkinCytarabineVincristineRecurrenceMyeloablative AgonistsCarmustineSurvival RateBone Marrow TransplantationHematopoietic Stem Cell MobilizationGraft vs Host DiseaseThiotepaSurvival AnalysisDoxorubicinBone Marrow PurgingHematologic NeoplasmsLymphoma, Mantle-CellWhole-Body IrradiationRetrospective StudiesAmyloidosisPrognosisHematopoietic Stem CellsDexamethasoneBoronic AcidsBusulfanPyrazinesFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedGraft SurvivalAntineoplastic Agents, AlkylatingIfosfamideLymphoma, FollicularPrednisoneAntineoplastic AgentsAntigens, CD34AutograftsLymphoma, T-Cell, PeripheralThalidomideLiver TransplantationLymphomaTime FactorsCisplatinGranulocyte Colony-Stimulating FactorInduction ChemotherapyMesenchymal Stem Cell TransplantationPodophyllotoxinLeukapheresisLymphoma, Large B-Cell, DiffuseNeoplasm, ResidualTransplantation ChimeraMaintenance ChemotherapyLeukemia, Myeloid, AcuteTissue DonorsCord Blood Stem Cell TransplantationCarboplatinMitoxantroneCell TransplantationLymphoma, B-CellDrug Administration ScheduleKidney TransplantationLeukemia, Plasma CellEnteropathy-Associated T-Cell LymphomaNeoplasms, Second PrimaryEmbryonic Stem CellsMyelodysplastic SyndromesIdarubicinInfusions, SpinalNeoplasm Recurrence, LocalProspective StudiesChemotherapy, AdjuvantAdult Stem CellsBlood Component RemovalBleomycinNeutropeniaImmunosuppressive AgentsFeasibility StudiesAntibodies, MonoclonalHistocompatibility TestingFatal OutcomeLeukemia, MyeloidNeoplasm StagingCell DifferentiationLeukemia